Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News May 8 2019 | New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN) Practice News Read More May 8 2019 | U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease Practice News Read More May 7 2019 | HFSA and NeedyMeds Partner for Patient & Caregiver Webinar: June 13 Practice News Read More May 5 2019 | HFSA President’s Update: May 2019 HFSA News President's Updates Read More May 3 2019 | Deadline Extended to May 15 for HFSA Nursing Award Nominations Practice News Read More Pagination First page « First Previous page ‹ Previous … Page 113 Page 114 Page 115 Page 116 Current page 117 Page 118 Page 119 Page 120 Page 121 … Next page Next › Last page Last »
May 8 2019 | New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN) Practice News Read More
May 8 2019 | U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease Practice News Read More
May 7 2019 | HFSA and NeedyMeds Partner for Patient & Caregiver Webinar: June 13 Practice News Read More
